LEXICON PHARMACEUTICALS $2.26

up +0.05


18/6/2013 04:18 PM  |  NASDAQ : LXRX  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
2/28/2013 MAIN ALAN J EVP, Pharmaceutical Research -12,572 $1.98 -9.87%
2/28/2013 Lapuerta Pablo EVP, Clin Dev and CMO -4,725 $1.98 -36.35%
2/28/2013 SANDS ARTHUR T President & CEO -20,034 $1.98 -2.08%
2/28/2013 Tessmer James F VP, Finance & Accounting -3,807 $1.98 -7.35%
2/28/2013 WADE JEFFREY L EVP, Corp Dev and CFO -10,461 $1.98 -8.62%
2/28/2013 ZAMBROWICZ BRIAN P EVP, Chief Scientific Officer -11,692 $1.98 -4.76%
1/31/2013 MAIN ALAN J EVP, Pharmaceutical Research -12,537 $2.11 -11.81%
1/31/2013 Tessmer James F VP, Finance & Accounting -4,310 $2.11 -10.29%
1/31/2013 ZAMBROWICZ BRIAN P EVP, Chief Scientific Officer -13,499 $2.11 -6.23%
1/31/2013 SANDS ARTHUR T President & CEO -21,434 $2.11 -2.35%
1/31/2013 WADE JEFFREY L EVP, Corp Dev and CFO -10,317 $2.11 -11.05%
10/23/2012 Invus, CV Senior Executive Officer 3,000,000 $2.25 1.07%
10/23/2012 Artal International S.C.A. Senior Executive Officer 3,000,000 $2.25 1.07%
2/28/2012 SANDS ARTHUR T President & CEO -9,588 $1.78 -1.13%
2/28/2012 ZAMBROWICZ BRIAN P EVP, Chief Scientific Officer -5,621 $1.78 -3.12%
2/28/2012 WADE JEFFREY L EVP, Corp Dev and CFO -4,959 $1.78 -7.43%
2/28/2012 MAIN ALAN J EVP, Pharmaceutical Research -5,907 $1.78 -9.20%
2/28/2012 Tessmer James F VP, Finance & Accounting -2,299 $1.78 -7.42%
12/22/2011 Ulys, LLC Senior Executive Officer 113,382,063 $1.13 82.77%
12/22/2011 Ulys, LLC Senior Executive Officer 1,622,184 $1.13 41.27%
12/22/2011 MAIN ALAN J EVP, Pharmaceutical Research 19,211 $1.13 42.72%
12/22/2011 BARKER SAM L Director 34,000 $1.13 51.52%
12/22/2011 SANDS ARTHUR T President & CEO 25,000 $1.13 3.18%
2/23/2011 MAIN ALAN J EVP, Pharmaceutical Research -5,926 $1.81 -11.64%
2/23/2011 Tessmer James F VP, Finance & Accounting -2,116 $1.81 -8.27%
2/23/2011 SANDS ARTHUR T President & CEO -10,464 $1.81 -1.31%
2/23/2011 WADE JEFFREY L EVP, Corp Dev and CFO -5,926 $1.81 -10.99%
2/23/2011 ZAMBROWICZ BRIAN P EVP, Chief Scientific Officer -7,881 $1.81 -4.73%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (LXRX), click here.
Marketplace
Trading Center